加尔多斯通道病变:对KCNN4突变及其临床影响的新见解
Prashant Warang1, Pradnya Dehadrai1, Neha Samanpalliwar1
1Department of Haematogenetics, ICMR-National Institute of Immunohematology, 13th Floor, NMS Building, King Edward Memorial (KEM) Hospital Campus, Parel, Mumbai, India.
加尔多斯通道病,一种罕见的溶血性贫血,是由KCNN4基因突变引起的. 这项研究在三名印度患者中发现了新的突变,突出显示了细胞内和氧化应激的升高作为关键疾病机制.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 格尔多斯通道病是一种罕见的遗传性血液溶解性贫血,与影响红细胞激活通道 (KCa3.1) 的KCNN4基因突变有关.
- 无法解释的慢性溶血性贫血症需要精确的基因诊断才能有效管理.
研究的目的:
- 确定三名印度患者无法解释的慢性血清性贫血的遗传基础.
- 鉴定KCNN4突变的临床和分子特征.
主要方法:
- 整体外基因组测序 (WES) 用于基因突变识别.
- 标准的血液学测试,包括红细胞酶检测和血红蛋白电泳.
- 流细胞计测量以评估细胞内水平和反应性氧物种 (ROS).
- 珀科尔密度梯度测定用于红细胞脱水评估.
主要成果:
- 确定了三种不同的KCNN4突变:c.5G>A (p.Gly2Asp) 同性,复合异性 (包括拼接位突变),c.541A>T (p.Ser181Cys) 同性.
- 所有患者都表现出慢性贫血,间接的高 bilirubinemia,网球细胞瘤,并需要输血.
- 所有患者都观察到细胞内和ROS度升高,这表明氧化应激.
- 红细胞脱水在一个案例中被发现,支持了诊断.
结论:
- 这项研究扩大了Gardos通道病变的已知突变谱.
- 下一代测序 (NGS) 对于诊断无法解释的溶血性贫血症至关重要.
- 细胞内的升高是血液溶解的关键因素,表明潜在的治疗标.
更多相关视频
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Lingo
